229 related articles for article (PubMed ID: 24524743)
1. CMR and amyloid cardiomyopathy: are we getting closer to the biology?
Kwong RY; Jerosch-Herold M
JACC Cardiovasc Imaging; 2014 Feb; 7(2):166-8. PubMed ID: 24524743
[No Abstract] [Full Text] [Related]
2. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
[TBL] [Abstract][Full Text] [Related]
4. Diffusion Tensor Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
Khalique Z; Ferreira PF; Scott AD; Nielles-Vallespin S; Martinez-Naharro A; Fontana M; Hawkins P; Firmin DN; Pennell DJ
Circ Cardiovasc Imaging; 2020 May; 13(5):e009901. PubMed ID: 32408830
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study.
Ueda M; Horibata Y; Shono M; Misumi Y; Oshima T; Su Y; Tasaki M; Shinriki S; Kawahara S; Jono H; Obayashi K; Ogawa H; Ando Y
Mod Pathol; 2011 Dec; 24(12):1533-44. PubMed ID: 21822203
[TBL] [Abstract][Full Text] [Related]
6. Pathological review of cardiac amyloidosis using autopsy cases in a single Japanese institution.
Tateishi Y; Yamada Y; Katsuki M; Nagata T; Yamamoto H; Kohashi K; Koga Y; Hashisako M; Kiyozawa D; Mori T; Kuboyama Y; Kakinokizono A; Miyazaki Y; Yamaguchi A; Tsutsui H; Ninomiya T; Naiki H; Oda Y
Pathol Res Pract; 2021 Nov; 227():153635. PubMed ID: 34653913
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Magnetic Resonance T
Duca F; Kammerlander AA; Panzenböck A; Binder C; Aschauer S; Loewe C; Agis H; Kain R; Hengstenberg C; Bonderman D; Mascherbauer J
JACC Cardiovasc Imaging; 2018 Dec; 11(12):1924-1926. PubMed ID: 30121265
[No Abstract] [Full Text] [Related]
8. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
Fontana M; Ćorović A; Scully P; Moon JC
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
[TBL] [Abstract][Full Text] [Related]
9. T1 mapping by CMR in cardiomyopathy: a noninvasive myocardial biopsy?
Kramer CM; Chandrashekhar Y; Narula J
JACC Cardiovasc Imaging; 2013 Apr; 6(4):532-4. PubMed ID: 23579019
[No Abstract] [Full Text] [Related]
10. Understanding and recognizing cardiac amyloidosis.
McVeigh T; Tennyson C
JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
[TBL] [Abstract][Full Text] [Related]
11. A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G > T, p.Ala140Ser).
Patel K; Tagoe C; Bieri P; Weidenheim K; Tauras JM
Amyloid; 2018 Sep; 25(3):211-212. PubMed ID: 30039724
[No Abstract] [Full Text] [Related]
12. Cardiac Amyloidosis: Updates in Imaging.
Chacko L; Martone R; Cappelli F; Fontana M
Curr Cardiol Rep; 2019 Aug; 21(9):108. PubMed ID: 31375984
[TBL] [Abstract][Full Text] [Related]
13. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.
Park MA; Padera RF; Belanger A; Dubey S; Hwang DH; Veeranna V; Falk RH; Di Carli MF; Dorbala S
Circ Cardiovasc Imaging; 2015 Aug; 8(8):. PubMed ID: 26259579
[TBL] [Abstract][Full Text] [Related]
14. [Suspected cardiac amyloidosis - diagnostic steps for evaluation].
Feldmann K; Hamm CW; Aßmus B
Dtsch Med Wochenschr; 2020 Aug; 145(16):1162-1168. PubMed ID: 32791553
[TBL] [Abstract][Full Text] [Related]
15. Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients.
Arbustini E; Merlini G; Gavazzi A; Grasso M; Diegoli M; Fasani R; Bellotti V; Marinone G; Morbini P; Dal Bello B
Am Heart J; 1995 Sep; 130(3 Pt 1):528-36. PubMed ID: 7661071
[TBL] [Abstract][Full Text] [Related]
16. Novel Cardiovascular Magnetic Resonance Model to Distinguish Immunoglobulin Light Chain From Transthyretin Cardiac Amyloidosis.
Slivnick JA; Tong MS; Nagaraja HN; Elamin MB; Wallner A; O'Brien A; Raman SV; Zareba KM
JACC Cardiovasc Imaging; 2021 Jan; 14(1):302-304. PubMed ID: 32950451
[No Abstract] [Full Text] [Related]
17. Atrial impairment in transthyretin cardiac amyloidosis: an early marker of cardiac involvement and a prognostic factor.
Di Bella G; Minutoli F
Amyloid; 2018 Jun; 25(2):135. PubMed ID: 29523040
[No Abstract] [Full Text] [Related]
18. [Classification of cardiac amyloidosis: an immunohistochemical analysis].
Li L; Duan XJ; Sun Y; Lu Y; Xu HY; Wang QZ; Wang HY
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):105-109. PubMed ID: 29429161
[No Abstract] [Full Text] [Related]
19. Early identification of transthyretin-related hereditary cardiac amyloidosis.
Arbustini E; Merlini G
JACC Cardiovasc Imaging; 2014 May; 7(5):511-4. PubMed ID: 24831211
[No Abstract] [Full Text] [Related]
20. Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging.
Kristen AV; aus dem Siepen F; Scherer K; Kammerer R; Andre F; Buss SJ; Bauer R; Lehrke S; Voss A; Giannitsis E; Katus HA; Steen H
Amyloid; 2015; 22(2):132-41. PubMed ID: 26053103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
